HIV prevalence and risks among injection and noninjection drug users in northern Thailand: Need for comprehensive HIV prevention programs

Myat Htoo Razak, Jaroon Jittiwutikam, Vinai Suriyanon, Tassanai Vongchak, Namtip Srirak, Christopher Beyrer, Surinda Kawichai, Sodsai Tovanabutra, Kittipong Rungruengthanakit, Pathom Sawanpanyalert, David D Celentano

Research output: Contribution to journalArticle

Abstract

The authors sought to determine sociodemographic and sexual and drug use risk factors for HIV infection among drug users in northern Thailand adjacent to the Golden Triangle. The authors enrolled patients admitted for inpatient drug detoxification at one treatment center in northern Thailand and studied HIV risks and prevalence using an interviewer-administered questionnaire and serum collection with HIV pretest and posttest counseling. Between February 1, 1999 and January 31, 2000, 1865 patients admitted for opiate and methamphetamine dependence completed study procedures. Overall HIV prevalence was 10.3%: 30.0% among 513 injection drug users (IDUs) and 2.8% among non-IDUs (OR = 14.8, 95% CI: 10.2, 21.6). HIV seroprevalence was 2.4% among exclusive methamphetamine users (98% of whom are nonIDUs) and 3.4% among opium smokers. Injection drug use was the dominant risk factor in multivariate models. Although Thailand is widely recognized as having a successful national response to the heterosexual HIV epidemic, seroprevalence in IDUs remains high. Despite a sharp increase of non-IDUs admitted to the drug treatment center, HIV infection and risks remained high among IDUs in northern Thailand. HIV prevention campaigns need to focus on IDUs and to implement harm reduction strategies to reduce transmission to IDUs and further contain the HIV epidemic in Thailand.

Original languageEnglish (US)
Pages (from-to)259-266
Number of pages8
JournalJournal of Acquired Immune Deficiency Syndromes
Volume33
Issue number2
StatePublished - Jun 1 2003

Fingerprint

Thailand
Drug Users
HIV
Injections
HIV Seroprevalence
Methamphetamine
HIV Infections
Substance Abuse Treatment Centers
Pharmaceutical Preparations
Opium
Harm Reduction
Opioid-Related Disorders
Heterosexuality
Counseling
Inpatients
Interviews
Serum

Keywords

  • Adolescents
  • Ethnic minorities
  • HIV-1 prevalence
  • Injection drug use
  • Methamphetamines
  • Thailand

ASJC Scopus subject areas

  • Virology
  • Immunology

Cite this

HIV prevalence and risks among injection and noninjection drug users in northern Thailand : Need for comprehensive HIV prevention programs. / Razak, Myat Htoo; Jittiwutikam, Jaroon; Suriyanon, Vinai; Vongchak, Tassanai; Srirak, Namtip; Beyrer, Christopher; Kawichai, Surinda; Tovanabutra, Sodsai; Rungruengthanakit, Kittipong; Sawanpanyalert, Pathom; Celentano, David D.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 33, No. 2, 01.06.2003, p. 259-266.

Research output: Contribution to journalArticle

Razak, MH, Jittiwutikam, J, Suriyanon, V, Vongchak, T, Srirak, N, Beyrer, C, Kawichai, S, Tovanabutra, S, Rungruengthanakit, K, Sawanpanyalert, P & Celentano, DD 2003, 'HIV prevalence and risks among injection and noninjection drug users in northern Thailand: Need for comprehensive HIV prevention programs', Journal of Acquired Immune Deficiency Syndromes, vol. 33, no. 2, pp. 259-266.
Razak, Myat Htoo ; Jittiwutikam, Jaroon ; Suriyanon, Vinai ; Vongchak, Tassanai ; Srirak, Namtip ; Beyrer, Christopher ; Kawichai, Surinda ; Tovanabutra, Sodsai ; Rungruengthanakit, Kittipong ; Sawanpanyalert, Pathom ; Celentano, David D. / HIV prevalence and risks among injection and noninjection drug users in northern Thailand : Need for comprehensive HIV prevention programs. In: Journal of Acquired Immune Deficiency Syndromes. 2003 ; Vol. 33, No. 2. pp. 259-266.
@article{520fa9e07c6c4237a9e821ca9c4826a5,
title = "HIV prevalence and risks among injection and noninjection drug users in northern Thailand: Need for comprehensive HIV prevention programs",
abstract = "The authors sought to determine sociodemographic and sexual and drug use risk factors for HIV infection among drug users in northern Thailand adjacent to the Golden Triangle. The authors enrolled patients admitted for inpatient drug detoxification at one treatment center in northern Thailand and studied HIV risks and prevalence using an interviewer-administered questionnaire and serum collection with HIV pretest and posttest counseling. Between February 1, 1999 and January 31, 2000, 1865 patients admitted for opiate and methamphetamine dependence completed study procedures. Overall HIV prevalence was 10.3{\%}: 30.0{\%} among 513 injection drug users (IDUs) and 2.8{\%} among non-IDUs (OR = 14.8, 95{\%} CI: 10.2, 21.6). HIV seroprevalence was 2.4{\%} among exclusive methamphetamine users (98{\%} of whom are nonIDUs) and 3.4{\%} among opium smokers. Injection drug use was the dominant risk factor in multivariate models. Although Thailand is widely recognized as having a successful national response to the heterosexual HIV epidemic, seroprevalence in IDUs remains high. Despite a sharp increase of non-IDUs admitted to the drug treatment center, HIV infection and risks remained high among IDUs in northern Thailand. HIV prevention campaigns need to focus on IDUs and to implement harm reduction strategies to reduce transmission to IDUs and further contain the HIV epidemic in Thailand.",
keywords = "Adolescents, Ethnic minorities, HIV-1 prevalence, Injection drug use, Methamphetamines, Thailand",
author = "Razak, {Myat Htoo} and Jaroon Jittiwutikam and Vinai Suriyanon and Tassanai Vongchak and Namtip Srirak and Christopher Beyrer and Surinda Kawichai and Sodsai Tovanabutra and Kittipong Rungruengthanakit and Pathom Sawanpanyalert and Celentano, {David D}",
year = "2003",
month = "6",
day = "1",
language = "English (US)",
volume = "33",
pages = "259--266",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - HIV prevalence and risks among injection and noninjection drug users in northern Thailand

T2 - Need for comprehensive HIV prevention programs

AU - Razak, Myat Htoo

AU - Jittiwutikam, Jaroon

AU - Suriyanon, Vinai

AU - Vongchak, Tassanai

AU - Srirak, Namtip

AU - Beyrer, Christopher

AU - Kawichai, Surinda

AU - Tovanabutra, Sodsai

AU - Rungruengthanakit, Kittipong

AU - Sawanpanyalert, Pathom

AU - Celentano, David D

PY - 2003/6/1

Y1 - 2003/6/1

N2 - The authors sought to determine sociodemographic and sexual and drug use risk factors for HIV infection among drug users in northern Thailand adjacent to the Golden Triangle. The authors enrolled patients admitted for inpatient drug detoxification at one treatment center in northern Thailand and studied HIV risks and prevalence using an interviewer-administered questionnaire and serum collection with HIV pretest and posttest counseling. Between February 1, 1999 and January 31, 2000, 1865 patients admitted for opiate and methamphetamine dependence completed study procedures. Overall HIV prevalence was 10.3%: 30.0% among 513 injection drug users (IDUs) and 2.8% among non-IDUs (OR = 14.8, 95% CI: 10.2, 21.6). HIV seroprevalence was 2.4% among exclusive methamphetamine users (98% of whom are nonIDUs) and 3.4% among opium smokers. Injection drug use was the dominant risk factor in multivariate models. Although Thailand is widely recognized as having a successful national response to the heterosexual HIV epidemic, seroprevalence in IDUs remains high. Despite a sharp increase of non-IDUs admitted to the drug treatment center, HIV infection and risks remained high among IDUs in northern Thailand. HIV prevention campaigns need to focus on IDUs and to implement harm reduction strategies to reduce transmission to IDUs and further contain the HIV epidemic in Thailand.

AB - The authors sought to determine sociodemographic and sexual and drug use risk factors for HIV infection among drug users in northern Thailand adjacent to the Golden Triangle. The authors enrolled patients admitted for inpatient drug detoxification at one treatment center in northern Thailand and studied HIV risks and prevalence using an interviewer-administered questionnaire and serum collection with HIV pretest and posttest counseling. Between February 1, 1999 and January 31, 2000, 1865 patients admitted for opiate and methamphetamine dependence completed study procedures. Overall HIV prevalence was 10.3%: 30.0% among 513 injection drug users (IDUs) and 2.8% among non-IDUs (OR = 14.8, 95% CI: 10.2, 21.6). HIV seroprevalence was 2.4% among exclusive methamphetamine users (98% of whom are nonIDUs) and 3.4% among opium smokers. Injection drug use was the dominant risk factor in multivariate models. Although Thailand is widely recognized as having a successful national response to the heterosexual HIV epidemic, seroprevalence in IDUs remains high. Despite a sharp increase of non-IDUs admitted to the drug treatment center, HIV infection and risks remained high among IDUs in northern Thailand. HIV prevention campaigns need to focus on IDUs and to implement harm reduction strategies to reduce transmission to IDUs and further contain the HIV epidemic in Thailand.

KW - Adolescents

KW - Ethnic minorities

KW - HIV-1 prevalence

KW - Injection drug use

KW - Methamphetamines

KW - Thailand

UR - http://www.scopus.com/inward/record.url?scp=0038417161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038417161&partnerID=8YFLogxK

M3 - Article

C2 - 12794564

AN - SCOPUS:0038417161

VL - 33

SP - 259

EP - 266

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 2

ER -